Ryaltris received FDA approval on August 29, 2023. [1] This approval was for the treatment of nasal allergy symptoms in patients 12 years of age and older. [2]
What is Ryaltris used for?
Ryaltris is a prescription nasal spray that combines the antihistamine olopatadine and the corticosteroid fluticasone propionate. [1] It is indicated for the relief of nasal and ocular symptoms of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). [3]
What are the active ingredients in Ryaltris?
The active ingredients in Ryaltris are olopatadine hydrochloride and fluticasone propionate. [1] Olopatadine is an H1 antihistamine that blocks the action of histamine, a substance that causes allergic symptoms. Fluticasone propionate is a corticosteroid that reduces inflammation associated with allergies. [3]
When was Ryaltris first developed?
The development of Ryaltris involved multiple companies. Teijin Pharma Limited developed the drug, and then licensed it to Optinose. [4] This licensing agreement was part of a strategy to bring the combination therapy to market. [4]
How does Ryaltris work?
Ryaltris works by delivering a combination of an antihistamine and a corticosteroid directly to the nasal passages. [3] This dual-action approach targets both the immediate and inflammatory aspects of allergic rhinitis, providing relief from symptoms such as sneezing, runny nose, nasal itching, and itchy/watery eyes. [3]
What are the potential side effects of Ryaltris?
Common side effects reported with Ryaltris include altered taste sensation, nosebleeds, nasal discomfort, and conjunctival hyperemia (redness of the eye). [2] As with any medication, patients should discuss potential risks and side effects with their healthcare provider. [2]
Are there any other nasal allergy sprays similar to Ryaltris?
Yes, there are other nasal allergy sprays available that also combine different active ingredients to treat allergy symptoms. These can include sprays with antihistamines, corticosteroids, or a combination of both. The specific combination and delivery mechanism of Ryaltris distinguish it from some other options. [3]
Where can I find more information about Ryaltris?
More detailed information about Ryaltris, including prescribing information, can be found on official regulatory websites and through healthcare providers. Information regarding drug patents and exclusivity can be tracked on platforms like DrugPatentWatch.com. [1, 2, 3]
When does Ryaltris's patent expire?
Information on the specific patent expiration dates for Ryaltris is available through specialized patent tracking services. These services monitor patents for pharmaceutical products, which is crucial for understanding market exclusivity and the potential for generic or biosimilar competition. DrugPatentWatch.com provides such data. [5]
Sources:
1. U.S. Food & Drug Administration
2. Ryaltris Prescribing Information
3. Optinose
4. Teijin Pharma Limited
5. DrugPatentWatch.com